object
design
develop
effect
vaccin
elicit
broadli
neutral
human
antibodi
bnab
remain
challeng
goal
extens
studi
reveal
variou
strategi
employ
viru
escap
host
immun
surveil
investig
human
antibodi
gene
repertoir
uninfect
individu
genom
dna
gdna
cdna
level
deep
sequenc
follow
highthroughput
sequenc
analysi
determin
frequenc
put
germlin
antibodi
gene
known
monoclon
bnab
bnmab
method
combinatori
gdna
cdna
antibodi
librari
construct
use
gdna
mrna
isol
uninfect
human
peripher
blood
mononuclear
cell
pbmc
librari
deep
sequenc
sequenc
analys
use
imgthighvquest
softwar
http
imgtorghighvquestindex
action
frequenc
put
germlin
antibodi
known
bnmab
gdna
cdna
librari
determin
human
gdna
antibodi
librari
divers
heavi
light
chain
vgene
lineag
usag
cdna
librari
indic
human
gdna
antibodi
gene
repertoir
may
potenti
cdna
repertoir
develop
bnab
frequenc
heavi
kappa
lambda
light
chain
variabl
region
ident
v
j
recombin
known
bnmab
extrem
low
human
antibodi
gene
repertoir
howev
found
rel
high
frequenc
heavi
kappa
lambda
light
chain
variabl
region
use
vgene
length
known
bnmab
regardless
jgene
usag
bcell
bear
bcell
receptor
heavi
kappa
lambda
light
chain
variabl
region
may
stimul
induc
bnab
sinc
discoveri
earli
effect
vaccin
elicit
bnab
yet
develop
extens
studi
reveal
variou
mechan
viral
escap
human
immun
surveil
includ
genet
alter
oligomer
envelop
env
glycoprotein
other
demonstr
known
bnmab
uncommon
properti
compar
bnmab
microb
includ
extens
somat
matur
lack
measur
bind
activ
put
germlin
antibodi
env
suggest
infect
vaccin
env
may
initi
somat
matur
process
put
germlin
ab
bnab
deep
sequenc
cdnapcr
product
memori
b
cell
obtain
sever
elit
control
differ
time
point
postinfect
reveal
limit
use
heavi
chain
vgene
ighv
lineag
develop
bnab
singl
infect
individu
infrequ
develop
bnab
natur
infect
uncommon
properti
known
bnmab
confin
usag
ighv
lineag
develop
bnab
singl
infect
individu
failur
induc
similar
bnmab
vaccin
immunogen
prompt
us
investig
human
antibodi
gene
repertoir
avail
put
germlin
antibodi
gene
known
bnmab
genom
dna
gdna
cdna
level
possibl
exist
altern
germlin
antibodi
gene
may
potenti
matur
bnab
gdna
peripher
b
cell
uninfect
human
individu
presum
possess
initi
rearrang
antibodi
gene
repertoir
affin
matur
upon
infect
vaccin
hypothes
antibodi
gene
repertoir
gdna
level
may
divers
cdna
level
therefor
develop
methodolog
construct
larg
combinatori
gdna
antibodi
librari
construct
one
larg
nonimmun
gdna
librari
use
pmbc
obtain
uninfect
healthi
human
three
immun
gdna
librari
use
pbmc
obtain
three
elit
control
correspond
cdna
librari
simultan
construct
compar
antibodi
gene
repertoir
four
gdna
antibodi
librari
correspond
cdna
librari
deep
sequenc
sequenc
analysi
result
suggest
frequenc
put
germlin
antibodi
gene
known
bnmab
extrem
low
altern
germlin
antibodi
gene
may
explor
elicit
bnab
prepar
human
peripher
blood
mononuclear
cell
pbmc
healthi
volunt
obtain
univers
hong
kong
hong
kong
china
pbmc
patient
one
obtain
aaron
diamond
aid
research
center
rockefel
univers
new
york
usa
pbmc
patient
obtain
nation
center
aid
std
control
prevent
china
cdc
beij
china
experi
approv
ethic
committe
respect
institut
conduct
accord
local
guidelin
regul
three
patient
elit
control
infect
clade
b
viru
whose
serum
exhibit
high
titr
broadli
neutral
activ
panel
bnmab
isol
pbmc
singl
memori
bcell
sort
use
cc
core
protein
bait
infect
clade
b
viru
naiv
antiretrovir
therapi
sera
also
exhibit
crossclad
neutral
activ
data
shown
heparin
whole
blood
sampl
use
isol
human
pbmc
ficol
densiti
gradient
separ
isol
genom
dna
total
rna
mrna
human
peripher
blood
mononuclear
cell
five
ten
million
pbmc
collect
ml
heparin
whole
blood
use
isol
gdna
total
rna
use
allprep
dnarna
mini
kit
qiagen
hilden
germani
follow
protocol
provid
manufactur
gdna
use
templat
amplif
heavi
chain
variabl
region
kappa
lambda
light
chain
variabl
region
seminest
pcr
construct
gdna
antibodi
singl
chain
antibodi
fragment
scfv
librari
phagemid
vector
total
rna
uninfect
individu
pbmc
pool
mrna
prepar
pool
total
rna
use
oligotex
mrna
mini
kit
qiagen
mrna
use
revers
transcrib
cdna
construct
cdna
antibodi
librari
construct
genom
dna
antibodi
scfv
librari
total
primer
design
use
seminest
pcr
reaction
amplifi
heavi
chain
kappa
lambda
light
chain
variabl
region
use
gdna
templat
soepcr
assembl
scfv
gdna
copyright
lippincott
william
wilkin
unauthor
reproduct
articl
prohibit
scfv
librari
construct
tabl
http
linkslww
revers
primer
mix
equal
molar
concentr
prior
seminest
pcr
sens
primer
anneal
leader
sequenc
framework
region
heavi
chain
variabl
region
kappa
lambda
light
chain
variabl
region
pair
correspond
mix
antisens
primer
use
final
concentr
mmoll
first
second
round
pcr
first
round
pcr
carri
reaction
volum
ml
contain
ng
gdna
templat
run
follow
pcr
programm
initi
denatur
min
cycl
cycl
extens
cycl
min
second
round
pcr
carri
use
correspond
first
round
pcr
product
templat
run
follow
pcr
programm
initi
denatur
min
cycl
extens
cycl
min
seminest
pcr
product
gelpurifi
use
qiaquick
gel
extract
kit
qiagen
purifi
heavi
chain
variabl
region
kappa
lambda
light
chain
variabl
region
coval
link
flexibl
linker
soepcr
assembl
scfv
use
primer
pair
soepcr
product
gelextract
digest
sfii
ligat
ligat
product
electropor
electrocompet
cell
pool
mrna
healthi
donor
pbmc
mrna
three
elit
control
use
revers
transcrib
cdna
use
superscript
iii
cdna
synthesi
kit
cdna
use
templat
amplifi
heavi
chain
variabl
region
kappalambda
light
chain
pcr
use
highfidel
dna
polymeras
primer
anneal
human
antibodi
heavi
chain
variabl
region
primer
anneal
constant
region
human
antibodi
light
chain
tabl
http
linkslwwcom
human
antibodi
heavi
chain
first
constant
domain
sequenc
attach
heavi
chain
variabl
region
soepcr
assembl
fd
light
chain
fd
assembl
soepcr
obtain
fab
fragment
fab
fragment
ligat
ligat
product
electropor
electrocompet
cell
deep
sequenc
sequenc
analysi
primer
anneal
vector
heavi
light
chain
constant
region
tabl
http
use
amplifi
scfv
gdna
antibodi
librari
fd
light
chain
cdna
antibodi
librari
gelpurifi
pcr
product
sent
deep
sequenc
use
roch
genom
sequenc
flx
trim
sequenc
nt
analys
use
imgthighvquest
softwar
http
imgtorghighvquestindexact
construct
larg
combinatori
dna
cdna
antibodi
librari
prepar
gdna
pbmc
uninfect
healthi
donor
amplifi
heavi
chain
variabl
region
kappa
lambda
light
chain
variabl
region
seminest
pcr
use
pool
gdna
templat
set
primer
anneal
leader
sequenc
framework
heavi
chain
kappa
lambda
light
chain
gene
famili
tabl
http
heavi
chain
variabl
region
kappa
lambda
light
chain
variabl
region
coval
link
flexibl
linker
strand
overlap
extens
soe
pcr
assembl
scfv
result
combinatori
gdna
scfv
librari
includ
two
sublibrari
design
nighgk
nighgl
contain
million
individu
clone
similarli
construct
three
immun
gdna
scfv
librari
use
gdna
isol
immun
gdna
scfv
librari
kappa
lambda
sublibrari
except
lambda
sublibrari
omit
five
sublibrari
design
sublibrari
contain
one
six
billion
individu
clone
simultan
construct
correspond
combinatori
cdna
antibodi
fab
librari
except
construct
cdna
fab
librari
use
pbmc
omit
isol
bnmab
singl
cell
sort
memori
bcell
pbmc
report
result
nonimmun
immun
cdna
fab
kappa
lambda
sublibrari
design
nihnik
nihnil
respect
sublibrari
contain
billion
individu
clone
divers
heavi
chain
vgene
lineag
usag
genom
dna
librari
cdna
librari
amplifi
scfv
gdna
librari
fd
light
chain
cdna
librari
use
primer
anneal
vector
constant
region
heavi
light
chain
cl
respect
tabl
http
linkslww
sent
pcr
product
deep
sequenc
obtain
trim
sequenc
nt
librari
rang
heavi
chain
variabl
region
kappa
light
chain
variabl
region
lambda
light
chain
variabl
region
sequenc
analysi
show
differ
pattern
copyright
lippincott
william
wilkin
unauthor
reproduct
articl
prohibit
use
variou
ighvand
igkviglv
kappa
lambda
light
chain
vgene
lineag
differ
gdna
cdna
librari
differ
gdna
correspond
cdna
librari
signific
nonimmun
immun
gdna
cdna
librari
fig
gdna
librari
divers
overal
cdna
librari
use
variou
ighv
lineag
fig
among
four
gdna
heavi
chain
librari
nigh
show
similar
pattern
variou
ighv
lineag
usag
wherea
significantli
differ
nigh
use
lineag
fig
compar
gdna
heavi
chain
librari
correspond
cdna
heavi
chain
librari
significantli
higher
percentag
clone
use
lineag
fig
bias
certain
subfamili
includ
ighv
fig
pattern
variou
igkviglv
lineag
usag
nonimmun
immun
gdna
librari
similar
except
librari
fig
nonimmun
immun
cdna
librari
also
show
similar
pattern
use
variou
igkviglv
lineag
nonimmun
immun
cdna
antibodi
librari
heavili
use
lineag
fig
result
indic
infect
shape
pattern
variou
ighv
lineag
usag
caus
chang
cdna
level
much
less
signific
compar
chang
gdna
level
differ
gdna
cdna
antibodi
gene
repertoir
uninfect
nonimmun
human
reflect
host
immun
regul
regul
may
larg
determin
hostdepend
immun
respons
infect
extrem
low
frequenc
heavi
chain
variabl
region
kappalambda
light
chain
variabl
region
ident
v
j
recombin
known
bnmab
investig
potenti
basal
human
antibodi
gene
repertoir
develop
bnab
analys
trim
heavi
chain
variabl
region
sequenc
count
number
heavi
chain
variabl
region
ident
put
vdj
recombin
five
known
bind
site
bnmab
two
glycan
loopspecif
bnmab
surpris
found
frequenc
heavi
chain
variabl
region
ident
put
vdj
recombin
known
bnmab
nonimmun
immun
gdna
cdna
librari
extrem
low
tabl
find
heavi
chain
variabl
region
ident
vdj
recombin
compar
known
bnmab
nonimmun
three
immun
gdna
librari
tabl
found
total
five
two
product
heavi
chain
variabl
region
infram
junction
cdna
librari
exactli
put
vdj
recombin
respect
tabl
howev
junction
region
length
differ
compar
respect
bnmab
data
shown
suggest
unlikelihood
matur
bnab
similar
search
heavi
chain
variabl
region
ident
vdj
recombin
nonneutr
weakli
neutral
mab
bnmab
sarscov
found
four
product
heavi
chain
variabl
region
two
immun
gdna
librari
total
product
heavi
chain
variabl
region
cdna
librari
nih
ident
put
vdj
recombin
heavi
chain
variabl
region
shorter
amino
acid
aa
found
one
heavi
chain
variabl
region
librari
one
heavi
chain
variabl
region
nih
librari
exactli
put
vdj
recombin
nigk
none
length
amino
acid
result
indic
chanc
heavi
chain
variabl
region
defin
vdj
recombin
along
specif
length
could
extrem
low
human
antibodi
gene
repertoir
frequenc
kappa
light
chain
variabl
region
ident
vj
recombin
known
bnmab
nonimmun
immun
gdna
cdna
librari
also
low
except
frequenc
kappa
light
chain
variabl
region
ident
vj
recombin
kappa
light
chain
variabl
region
rel
high
tabl
use
vj
recombin
frequenc
kappa
light
chain
variabl
region
ident
vj
recombin
also
rel
high
interestingli
found
frequenc
lambda
light
chain
variabl
region
ident
vj
recombin
bnmab
also
rel
high
wherea
frequenc
kappa
light
chain
variabl
region
ident
vj
recombin
low
tabl
rel
high
frequenc
heavi
kappa
lambda
light
chain
variabl
region
use
similar
heavi
chain
gene
kappalambda
light
chain
vgene
length
known
bnmab
regardless
jgene
usag
usual
difficult
determin
dgene
jgene
recombin
vgene
gener
heavi
chain
variabl
region
owe
complex
vdj
recombin
event
therefor
search
product
heavi
chain
variabl
region
use
similar
ighv
length
known
bnmab
regardless
dgene
jgene
usag
frequenc
heavi
chain
variabl
rel
high
nonimmun
immun
gdna
cdna
librari
frequenc
heavi
chain
variabl
region
exactli
vdj
recombin
known
bnmab
except
long
amino
acid
respect
tabl
also
long
amino
acid
frequenc
heavi
chain
variabl
region
use
similar
ighv
length
higher
frequenc
heavi
chain
variabl
region
exactli
vdj
recombin
similar
analysi
trim
kappalambda
light
chain
variabl
region
also
show
rel
high
frequenc
vksvl
use
similar
igkvsiglv
length
known
bnmab
regardless
jgene
usag
especi
tabl
human
genom
dna
antibodi
repertoir
zhang
et
al
tabl
number
product
heavi
chain
variabl
region
kappalambda
light
chain
variabl
region
ident
put
v
j
recombin
known
bnmab
ighv
ighd
ighj
nigh
nih
f
found
frequenc
heavi
chain
variabl
region
kappalambda
light
chain
variabl
region
ident
put
v
j
recombin
known
bnmab
extrem
low
nonimmun
gdna
cdna
librari
suggest
known
bnmab
may
deriv
put
germlin
antibodi
chanc
direct
matur
may
low
certain
combin
put
germlin
heavi
light
chain
requir
bnab
frequenc
germlin
antibodi
gene
may
even
lower
compar
lack
measur
bind
put
germlin
antibodi
known
bnmab
env
requir
extens
somat
matur
broadli
neutral
activ
limit
avail
bcell
bear
proper
germlin
antibodi
gene
may
matur
bnab
upon
stimul
may
formid
challeng
develop
effect
vaccin
extrem
low
frequenc
put
germlin
antibodi
gene
known
bnmab
human
antibodi
gene
repertoir
suggest
approach
elicit
bnab
identifi
primari
immunogen
trigger
put
germlin
antibodi
known
bnmab
vivo
may
limit
chanc
success
howev
sequenc
analys
reveal
rel
high
frequenc
heavi
chain
variabl
region
kappalambda
light
chain
variabl
region
human
antibodi
gene
repertoir
use
similar
ighv
igkvsiglv
length
known
bnmab
regardless
jgene
usag
bcell
harbour
heavi
chain
variabl
region
kappalambda
light
chain
variabl
region
may
stimul
induc
bnab
note
use
plasmid
cdna
fab
librari
gdna
scfv
librari
templat
pcr
amplif
heavi
chain
variabl
region
kappalambda
light
chain
variabl
region
deep
sequenc
cdna
fab
librari
construct
earlier
use
previou
studi
convert
fab
librari
scfv
librari
necessari
convers
two
differ
format
antibodi
librari
may
caus
loss
antibodi
divers
result
bia
certain
antibodi
gene
famili
explor
human
gdna
antibodi
gene
repertoir
may
anoth
approach
elicit
bnab
hypothes
gdna
antibodi
gene
repertoir
show
divers
usag
ighv
lineag
cdna
repertoir
inde
isol
panel
antibodi
combinatori
gdna
librari
cdna
librari
manuscript
prepar
isol
antibodi
low
level
somat
matur
use
divers
v
j
recombin
compet
matur
bind
engin
env
suggest
potenti
matur
bnab
current
invitro
matur
select
confirm
potenti
matur
bnab
obtain
trim
heavi
chain
variabl
region
sequenc
deep
sequenc
nonimmun
gdna
cdna
librari
respect
tabl
compar
theoret
maximum
divers
basal
human
heavi
chain
variabl
gene
repertoir
unequ
usag
ighv
ighd
ighj
gene
nonimmun
gdna
librari
suggest
vdj
recombin
may
random
event
differ
may
amplifi
host
immun
regul
remov
function
silenc
bcell
express
autoimmun
antibodi
deplet
bcell
recogn
bcell
superantigen
could
lead
differ
frequenc
variou
germlin
antibodi
gene
initi
antibodi
gene
repertoir
affin
matur
exampl
heavi
chain
variabl
region
use
long
length
amino
acid
significantli
less
frequent
heavi
chain
variabl
region
use
medium
length
amino
acid
fig
data
shown
arnaout
et
al
also
show
v
j
segment
util
differ
frequenc
result
highli
skew
represent
vdj
combin
human
antibodi
gene
repertoir
howev
found
pattern
segment
usag
almost
ident
two
differ
individu
result
seem
differ
find
found
ighv
lineag
usag
differ
individu
individu
addit
report
lineag
account
sequenc
nonimmun
human
antibodi
gene
repertoir
found
similar
percentag
cdna
librari
percentag
